Search
Close this search box.

Seattle Genetics, Inc.  

Company Name: Seattle Genetics, Inc.

Seattle Genetics, Inc. is a biotechnology company. The company is engaged in the development and commercialization of antibody-based therapies designed to treat cancer. The company’s antibody-drug conjugate (ADC) technology is designed to allow cell killing agents to be delivered directly to cancer cells. ADCETRIS®, the company’s lead product, is approved in over 50 countries.

Ticker Symbol: SGEN (NASDAQ)

Company Website: www.seattlegenetics.com

Social Media:

Seattle Genetics LinkedIn

Seattle Genetics Twitter

Classification: Biotech

Areas of Focus:

Cancer

Antibodies

Headquarters: Bothell, WA

Related Links:

List of Healthcare Companies

List of Pharmaceutical Companies

Publicly Traded Companies in Washington

Publicly Traded Companies by Sector and Industry

Large-Cap Biotech Stocks

Mid-Cap Biotech Stocks

Small-Cap Biotech Stocks

Micro-Cap Biotech Stocks

Nano-Cap Biotech Stocks